New Epigenetic Clocks Redefine Our Understanding of Aging

Scientists have made a remarkable breakthrough in the field of aging research by developing innovative “epigenetic clocks” that offer deeper insights into the factors that drive aging. This groundbreaking study, conducted by researchers at Brigham and Women’s Hospital, has revolutionized our understanding of aging by delving into the intricate realm of epigenetics.

Epigenetics is the study of heritable changes in phenotype that do not involve changes in the underlying DNA sequence. By analyzing DNA methylation patterns, the researchers have created an epigenetic clock that more accurately predicts biological age compared to previous models. This new approach not only determines biological age but also distinguishes between genetic factors that accelerate aging and those that decelerate it.

Unlike previous epigenetic clocks that only predict biological age based on methylation patterns and aging-related features, the clocks developed in this study go a step further. They not only determine the biological age of cells but also provide insight into the factors that cause or slow down aging. This distinction is crucial in understanding the mechanisms behind aging and assessing the efficacy of aging interventions.

The researchers focused their investigation on specific DNA regions called CpG sites, which have a strong link to the aging process. Lifestyle choices, genetic inheritance, and various other factors can affect the DNA methylation of these CpG sites, thereby influencing the pace of aging. By identifying 20,509 CpG sites linked to eight aging-related traits, the researchers created three clock models: CausAge, DamAge, and AdaptAge.

CausAge predicts biological age based on the causal DNA factors that accelerate or counteract aging. DamAge is associated with adverse outcomes such as mortality, while AdaptAge is linked to favorable adjustments. Testing these models on thousands of blood samples, the researchers developed a map pinpointing the CpG sites responsible for biological aging. These biomarkers could be used to evaluate interventions aimed at promoting longevity or slowing down aging.

While further testing is required to refine age measurement accuracy, these new epigenetic clocks have already demonstrated their ability to recognize the impact of short-term actions on aging. By identifying specific DNA regions that significantly affect lifespan and health span, this study opens up new avenues for exploring methods to slow down aging and potentially reverse age-related changes. These findings represent a significant step forward for aging research, offering a more accurate quantification of biological age and evaluation of novel aging interventions.

FAQ:

1. What is the breakthrough in the field of aging research?
Scientists have developed innovative “epigenetic clocks” that offer deeper insights into the factors that drive aging. These clocks use DNA methylation patterns to predict biological age more accurately than previous models.

2. What is epigenetics?
Epigenetics is the study of heritable changes in phenotype that do not involve changes in the underlying DNA sequence. It focuses on how gene expression is regulated and influenced by various factors.

3. How do these epigenetic clocks work?
The epigenetic clocks developed in this study analyze DNA methylation patterns in specific DNA regions called CpG sites. By identifying CpG sites linked to aging-related traits, the clocks can predict biological age and provide insight into aging acceleration or deceleration factors.

4. What are the names of the clock models developed?
The researchers created three clock models: CausAge, DamAge, and AdaptAge. CausAge predicts biological age based on the causal DNA factors that accelerate or counteract aging. DamAge is associated with adverse outcomes such as mortality, while AdaptAge is linked to favorable adjustments.

5. What can these epigenetic clocks be used for?
The epigenetic clocks can be used to evaluate interventions aimed at promoting longevity or slowing down aging. The identified CpG sites responsible for biological aging can serve as biomarkers to assess the efficacy of aging interventions.

6. What are the implications of this study?
This study represents a significant step forward for aging research as it offers a more accurate quantification of biological age and evaluation of novel aging interventions. It opens up new avenues for exploring methods to slow down aging and potentially reverse age-related changes.

Definition:
– Epigenetics: The study of heritable changes in phenotype that do not involve changes in the underlying DNA sequence.

Related Links:
Brigham and Women’s Hospital

The source of the article is from the blog yanoticias.es

Privacy policy
Contact